Seroincidence of human T-lymphotropic virus type I infection and characterization of seroconverters in Jamaican food handlers

Journal of Acquired Immune Deficiency Syndromes

Volumn 33, Issue 3, 2003, Pages 387-392

  Van Veldhuisen, Paul C ^a,b   Walters, Michael ^c   Sawada, Takashi ^d   Levine, Paul H ^a   Wilks, Rainford ^e   Hanchard, Barrie ^f   Hisada, Michie ^g  

^a G W Univ Sch Pub Hlth/Hlth S   (United States)

^b EMMES CORPORATION   (United States)

^c SAIC FREDERICK INC   (United States)

^d EISAI CO LTD   (Japan)

^e UNIVERSITY OF THE WEST INDIES   (Jamaica)

^f UNIVERSITY OF THE WEST INDIES   (Jamaica)

^g NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Anti Tax; Antibody titer; HTLV I; Jamaica; Provirus load; Seroincidence

Indexed keywords

REGULATOR PROTEIN; TAX PROTEIN; VIRUS ANTIBODY;

ADULT; AGE; AGED; ARTICLE; COHORT ANALYSIS; COMPARATIVE STUDY; FEMALE; FOLLOW UP; FOOD HANDLING; GENDER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INCIDENCE; JAMAICA; MALE; NORMAL HUMAN; POPULATION RESEARCH; PRIORITY JOURNAL; PROVIRUS; SCHOOL CHILD; SEROCONVERSION; SEROLOGY; VIRUS CARRIER; VIRUS LOAD; VIRUS TITRATION;

EID: 0038163699     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/00126334-200307010-00014     Document Type: Article

References (39)

1. Poiesz BJ, Ruscetti FW, Gazdar AF, et al. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci U S A. 1980;77:7415-7419.
2. Miyoshi I, Kubonishi I, Yoshimoto S, et al. Type C virus particles in a cord T-cell line derived by co-cultivating normal human cord leukocytes and human leukaemic T-cells. Nature. 1981;294:770-771.
3. Gessain A, Barin F, Vernant JC, et al. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet. 1985;2:407-410.
4. Osame M, Usuku K, Izumo S, et al. HTLV-I associated myelopathy, a new clinical entity. Lancet. 1986;1:1031-1032.
5. LaGrenade L, Hanchard B, Fletcher V, et al. Infective dermatitis of Jamaican children: a marker for HTLV-I Infection. Lancet. 1990;336:1345-1347.
6. Mochizuki M, Watanabe T, Yamaguchi K, et al. HTLV-I uveitis: a distinct clinical entity caused by HTLV-I. Jpn J Cancer Res. 1992;83:236-239.
7. Arisawa K, Soda M, Akahoshi M, et al. Human T-lymphotropic virus type-I infection, antibody titers and cause-specific mortality among atom bomb survivors. Jpn J Cancer Res. 1998;89:797-805.
8. Manns A, Hisada M, La Grenade L. Human T-lymphotropic virus type I infection. Lancet. 1999;353:1951-1958.
9. Okochi K, Sato H, Hinuma Y. A retrospective study on transmission of adult T cell leukemia virus by blood transfusion: seroconversion in recipients. Vox Sang. 1984;46:245-253.
10. Manns A, Wilks RJ, Murphy EL, et al. A prospective study of transmission by transfusion of HTLV-I and risk factors associated with seroconversion. Int J Cancer. 1992;51:886-891.
11. Yoshida M, Osame M, Kawai H, et al. Increased replication of HTLV-I in HTLV-I-associated myelopathy. Ann Neurol. 1989;26:331-335.
12. Kira J, Koyanagi Y, Yamada T, et al. Increased HTLV-I proviral DNA in HTLV-I-associated myelopathy: a quantitative polymerase chain reaction study. Ann Neurol. 1991;29:194-201.
13. Wattel E, Mariotti M, Agis F, et al. Quantification of HTLV-I proviral copy number in peripheral blood of symptomless carriers in the French West Indies. J Acquir Immune Defic Syndr. 1992;5:943-946.
14. Manns A, Miley WJ, Wilks RJ, et al. Quantitative proviral DNA and antibody levels in the natural history of HTLV-I infection. J Infect Dis. 1999;180:1487-1493.
15. Hisada M, Okayama A, Shioiro S, et al. Risk factors for adult T-cell leukemia among carriers of human T-lymphotropic virus type I. Blood. 1998;92:3557-3561.
16. Taylor GP, Tosswill JH, Matutes E, et al. Prospective study of HTLV-I infection in an initially asymptomatic cohort. J Acquir Immune Defic Syndr. 1999;22:92-100.
17. Ehrlich GD, Glaser JB, Abbott MA, et al. Detection of anti-HTLV-I Tax antibodies in HTLV-I enzyme-linked immunosorbent assay-negative individuals. Blood. 1989;74:1066-1072.
18. Rosen CA, Park R, Sodroski JG, et al. Multiple sequence elements are required for regulation of human T-cell leukemia virus gene expression. Proc Natl Acad Sci U S A. 1987;84:4919-4923.
19. Seiki M, Inoue J, Hidaka M, et al. Two cis-acting elements responsible for posttranscriptional trans-regulation of gene expression of human T-cell leukemia virus type I. Proc Natl Acad Sci U S A. 1988;85:7124-7128.
20. Murphy EL, Figueroa JP, Gibbs WN, et al. Human T-lymphotropic virus type I (HTLV-I) seroprevalence in Jamaica. I. Demographic determinants. Am J Epidemiol. 1991;133:1114-1124.
21. Maloney EM, Murphy EL, Figueroa JP, et al. Human T-lymphotropic virus type I (HTLV-I) seroprevalence in Jamaica. II. Geographical and ecologic determinants. Am J Epidemiol. 1991;133:1125-1134.
22. Murphy EL, Wilks R, Hanchard B, et al. A case-control study of risk factors for seropositivity to human T-lymphotropic virus type I (HTLV-I) in Jamaica. Int J Epidemiol. 1996;25:1083-1089.
23. Murphy EL, Wilks R, Morgan OS, et al. Health effects of human T-lymphotropic virus type-I (HTLV-I) in a Jamaican cohort. Int J Epidemiol. 1996;25:1090-1097.
24. Wiktor SZ, Alexander SS, Shaw GM, et al. Distinguishing between HTLV-I and HTLV-II by western blot. Lancet. 1990;335:1533.
25. tax antibody-positive mothers. Jpn J Cancer Res. 1989;80:506-508.
26. Miley WJ, Suryanarayana K, Manns A, et al. Real-time polymerase chain reaction assay for cell-associated HTLV type I DNA viral load. AIDS Res Hum Retroviruses. 2000;16:665-675.
27. Breslow NW, Day NE. Statistical Methods in Cancer Research. Vol II. The Design and Analysis of Cohort Studies. Lyon: International Agency for Research on Cancer, 1997.
28. Rothman KJ, Boice JD Jr. Epidemiological Analysis with a Programmable Calculator. Boston: Epidemiology Resources, Inc, 1982.
29. Mueller N. The epidemiology of HTLV-I infection. Cancer Causes Control. 1991;2:37-52.
30. Takezaki T, Tajima K, Komoda H, et al. Incidence of human T lymphotropic virus type I seroconversion after age 40 among Japanese residents in an area where the virus is endemic. J Infect Dis. 1995;171:559-565.
31. Hisada M, Maloney EM, Sawada T, et al. Virus markers associated with vertical transmission of human T lymphotropic virus type 1 in Jamaica. Clin Infect Dis. 2002;34:1551-1557.
32. Kajiyama W, Kashiwagi S, Ikematsu H, et al. Intrafamilial transmission of adult T-cell leukemia virus. J Infect Dis. 1986;154:851-857.
33. Stuver SO, Mueller NE. Re: Sexual transmission of human T-lymphotropic virus type I among female prostitutes and among patients with sexually transmitted diseases in Fukuoka, Kyushu, Japan. Am J Epidemiol. 1995;142:1247-1248.
34. Mueller N, Okayama A, Stuver S, et al. Findings from the Miyazaki cohort study. J Acquir Immune Defic Syndr Hum Retrovirol. 1996;13(suppl 1):S2-S7.
35. Hinuma S, Komoda H, Chosa T, et al. Antibodies to adult T-cell leukemia-virus-associated antigen (ATLA) in sera from patients with ATL and controls in Japan: a nation-wide seroepidemiologic study. Int J Cancer. 1982;29:631-635.
36. Okayama A, Stuver S, Iga M, et al. Sequential change of virus markers in seroconverters with community-acquired infection of human T lymphotropic virus type I. J Infect Dis. 2001;183:1031-1037.
37. Manns A, Murphy EL, Wilks R, et al. Detection of human T-cell lymphotropic virus type I antibody patterns during seroconversion among transfusion recipients. Blood. 1991;77:896-905.
38. Yokota T, Cho MJ, Tachibana N, et al. The prevalence of antibody to p42 of HTLV-I among ATLL patients in comparison with healthy carriers in Japan. Int J Cancer. 1989;43:970-974.
39. Shioiri S, Tachibana N, Okayama A, et al. Analysis of anti-Tax antibody of HTLV-I carriers in an endemic area in Japan. Int J Cancer. 1993;53:1-4.